FDA approves first drug to fight severe forms of MS

Being diagnosed with multiple sclerosis (MS) is seen as a life sentence, as the disease can seriously affect a sufferer’s motor skills and cognitive abilities, but new hope might be on the way. This week, the US Food and Drug Administration (FDA) has approved a new drug, called ocrelizumab, which fights MS by targeting the body’s B cells and is the first to have an effect on the more severe form of the disease.

Michael Irving

Full Story: http://newatlas.com/ms-drug-ocrelizumab-approved-fda/48682/?utm_source=Gizmag+Subscribers&utm_campaign=b2eea916c8-UA-2235360-4&utm_medium=email&utm_term=0_65b67362bd-b2eea916c8-92465361